Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Biosimilars
42 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Interchangeable Biosimilars
The Opportunities and Challenges Posed by Biosimilar Interchangeability
PAO-03-23-NI-01
Life Science Industrials
Filling Industry Gaps and Driving Innovation with Life Science Industrials
PAO-11-21-CL-01
Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra®
PR-M06-21-010
Clinical Trial Logistics
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
PAO-03-21-CL-06
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
PAO-03-21-CL-03
Parenterals
Trends Shaping the Dynamic Market for Parenterals
PAP-Q3-20-CL-018
The Future of Healthcare
How Is Polpharma Biologics Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-007
The Future of Healthcare
How is Polpharma Biologics Innovating through the Integration of Advanced Cell Line Development Capabilities to Help Shape the Future of Healthcare?
PAP-Q2-20-RT2-004
Biosimilar
iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar
PR-M04-20-NI-014
Biosimilars
Numerous Biosimilar Launches Coming Soon in United States
PAO-M12-19-NI-007
Biosimilars
Is the U.S. Biosimilars Market Poised for Takeoff?
PAP-Q3-19-CL-015
Biosimilars
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
PR-M07-19-NI-058
Biosimilars
Accelerating Biosimilar Development
PAP-Q1-2019-CL-014
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on New Actions Advancing the Agency's Biosimilars Policy Framework
PR-M12-18-NI-049
Biosimilars
Pfizer’s Rituximab Biosimilar Achieves Positive Study Results
PAO-M12-18-NI-001
FDA Approval
FDA Approves First Biosimilar for Treatment of Adult Patients with Non-Hodgkin's Lymphoma
PR-M12-18-NI-004
Biosimilar
Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
PR-M09-18-NI-087
Biosimilar
FDA Issues New Biosimilar Action Plan
PR-M07-18-NI-074
FDA Approval
Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA
PR-M05-18-NI-071
Biosimilars
GlobalData Predicts Strong Sales for Humira Biosimilars in Europe
PAO-M05-18-NI-006
Approval
Celltrion Receives EU Approval for Trastuzumab Biosimilar
PR-M02-18-NI-71
Biosimilars
Novartis Makes More Biosimilar Moves
PAO-M01-18-NI-047
Biosimilars
Sandoz - Biocon Deal One More Sign That U.S. Biosimilars Have Arrived
PR-M01-18-NI-086
Biosimilar
European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
PR-M01-18-NI-077
1
2
»
